Nerve growth factor, ganglioside and vitamin E reverse glutamate cytotoxicity in hippocampal cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  European Journal of Pharmacology

• Publication date

  1999-02-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-2999(98)00942-XPMID 10082272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nerve growth factor-induced neurite formation in PC12 cells is independent of endogenous cellular gangliosides.

  1998cited by this paper
• GM1 Ganglioside: In Vivo and In Vitro Trophic Actions on Central Neurotransmitter Systems

  1998cited by this paper
• GM1 increases the content and mRNA of NGF in the brain of aged rats

  1997cited by this paper
• Ganglioside GM1 Enhances Induction by Nerve Growth Factor of a Putative Dimer of TrkA

  1997cited by this paper
• Gangliosides inhibit growth factor‐stimulated neurite outgrowth in SH‐SY5Y human neuroblastoma cells

  1997cited by this paper
• Nonmuscle Myosin Heavy Chain B Is Recognized by a Monoclonal Antibody that Inhibits GM1‐Enhanced Neuritogenesis

  1997cited by this paper
• Effects of gangliosides, ouabain and arachidonic acid on glutamate cytotoxicity in PC12 cells.

  1997cited by this paper
• Ascorbate attenuates the systemic kainate-induced neurotoxicity in the rat hippocampus.

  1996cited by this paper
• Cellular and molecular mechanisms of ischemic brain damage

  1996cited by this paper
• Excitotoxicity and excitoprotection in vitro.

  1996cited by this paper
• Neurotrophic Factors Attenuate Glutamate‐Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons

  1995cited by this paper
• Deferoxamine Posttreatment Reduces Ischemic Brain Injury in Neonatal Rats

  1994cited by this paper
• Endogenous Neuroprotection Factors and Traumatic Brain Injury: Mechanisms of Action and Implications for Therapy

  1994cited by this paper
• Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons.

  1993cited by this paper
• Transforming Growth Factor-β1 Prevents Glutamate Neurotoxicity in Rat Neocortical Cultures and Protects Mouse Neocortex from Ischemic Injury in vivo

  1993cited by this paper
• Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum.

  1993cited by this paper
• Basic FGF, NGF, and IGFs Protect Hippocampal and Cortical Neurons against Iron-Induced Degeneration

  1993cited by this paper
• NMDA-dependent superoxide production and neurotoxicity

  1993cited by this paper
• Neurotrophic factor mediated protection from excitotoxicity and disturbances in calcium and free radical metabolism

  1993cited by this paper
• Gangliosides and Neurotrophic Factors in Neurodegenerative Diseases: From Experimental Findings to Clinical Perspectives

  1993cited by this paper
• Growth factors and vitamin E modify neuronal glutamate toxicity.

  1992cited by this paper
• Growth factor signaling by receptor tyrosine kinases.

  1992cited by this paper
• NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats.

  1992cited by this paper
• Gangliosides prevent the inhibition by K-252a of NGF responses in PC12 cells.

  1992cited by this paper
• Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration

  1992cited by this paper
• Oxidative stress in mitochondria: its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation.

  1991cited by this paper
• The trk proto-oncogene encodes a receptor for nerve growth factor.

  1991cited by this paper
• Death of cultured hippocampal pyramidal neurons induced by pathological activation of N-methyl-D-aspartate receptors is reduced by monosialogangliosides.

  1991cited by this paper
• Temporal changes in edema, Na+, K+, and Ca++ in focal cortical stroke: GM1 ganglioside reduces ischemic injury

  1991cited by this paper
• Amelioration of delayed neuronal death in the hippocampus by nerve growth factor

  1991cited by this paper
• Oxygen free radicals and brain dysfunction.

  1991cited by this paper
• Cholecystokinin-induced protection of cultured cortical neurons against glutamate neurotoxicity.

  1991cited by this paper
• The mechanism of action of nerve growth factor.

  1991cited by this paper
• The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.

  1991cited by this paper
• Redox modulation of NMDA receptor-mediated toxicity in mammalian central neurons.

  1990cited by this paper
• Redox modulation of NMDA receptor-mediated Ca2+ flux in mammalian central neurons.

  1990cited by this paper
• Glycosphingolipids that can regulate nerve growth and repair.

  1990cited by this paper
• Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous sphingolipids.

  1990cited by this paper
• 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures.

  1990cited by this paper
• Correlation Between Attenuation of Posttraumatic Spinal Cord Ischemia and Preservation of Tissue Vitamin E by the 21-Aminosteroid U74006F: Evidence for an In Vivo Antioxidant Mechanism

  1989cited by this paper
• Roles for mitotic history in the generation and degeneration of hippocampal neuroarchitecture

  1989cited by this paper
• Role of Ca2+ in toxic cell killing.

  1989cited by this paper
• Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex.

  1988cited by this paper
• Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor.

  1988cited by this paper
• Oxidants and human disease: some new concepts 1

  1987cited by this paper
• Ionic dependence of glutamate neurotoxicity

  1987cited by this paper
• Glycine potentiates the NMDA response in cultured mouse brain neurons

  1987cited by this paper
• Acute effects of GM1 ganglioside: reduction in both behavioral asymmetry and loss of Na+, K+-ATPase after nigrostriatal transection.

  1986cited by this paper
• Gangliosides enhance neurite outgrowth in PC12 cells.

  1983cited by this paper
• The nerve growth factor: biochemistry, synthesis, and mechanism of action.

  1980cited by this paper

• High levels of NGF during anxiety-like behavior in a murine model of brain ischemic stroke

  2020cites this paper
• Validation and identification of serum biomarkers to predict neurological recovery after acute spinal cord injury

  2019cites this paper
• Drug Dosing in Acute Kidney Injury

  2018cites this paper
• Association between Serum Nerve Growth Factor Levels and Depression in Stroke Patients

  2017cites this paper
• Alterations on Na+,K+-ATPase and Acetylcholinesterase Activities Induced by Amyloid-β Peptide in Rat Brain and GM1 Ganglioside Neuroprotective Action

  2013cites this paper
• An investigation into the combined effects of β-amyloid toxicity and cerebral ischemia on the pathological expression of gangliosides.

  2012cites this paper
• Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action.

  2011cites this paper
• The neuroprotective effects of NGF combined with GM1 on injured spinal cord neurons in vitro.

  2009cites this paper
• Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals

  2009cites this paper
• GM1 and NGF modulate Ca2+ homeostasis and GAP43 mRNA expression in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate

  2007cites this paper
• The effect of alpha-Tocopherol supplementation on training-induced elevation of S100B protein in sera of basketball players.

  2007cites this paper
• α-Tocopherol supplementation reduces the elevated 8-hydroxy-2-deoxyguanosine blood levels induced by training in basketball players

  2006cites this paper
• Spinal Cord Injury Repair Strategies

  2005cites this paper
• Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.

  2004cites this paper
• Activation of MAPK and CREB by GM1 induces survival of RGCs in the retina with axotomized nerve.

  2003cites this paper
• Tocopherols enhance neurogenesis in dentate gyrus of adult rats.

  2002cites this paper
• Nerve growth factor signaling, neuroprotection, and neural repair.

  2001cites this paper
• Sodium azide treatment decreases striatal and cortical concentrations of α-tocopherol in rats

  2001cites this paper
• The Sygen® Multicenter Acute Spinal Cord Injury Study

  2001cites this paper
• Sodium azide treatment decreases striatal and cortical concentrations of alpha-tocopherol in rats.

  2001cites this paper
• Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.

  2000cites this paper